Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced non-small cell lung cancer.
Vita E, Monaca F, Milardi D, Mastrantoni L, Stefani A, Vergani E, Russo J, Barone D, Sparagna I, Vitale A, Scala A, Occhipinti D, Di Salvatore M, Pontecorvi A, Tortora G, Bria E. Vita E, et al. Among authors: sparagna i. Cancer. 2024 Aug 1;130(15):2611-2620. doi: 10.1002/cncr.35293. Epub 2024 Mar 28. Cancer. 2024. PMID: 38549441
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC).
Vita E, Stefani A, Piro G, Mastrantoni L, Cintoni M, Cicchetti G, Sparagna I, Monaca F, Horn G, Russo J, Barone D, Di Salvatore M, Trisolini R, Lococo F, Mazzarella C, Cancellieri A, Carbone C, Larici AR, Mele MC, Pilotto S, Milella M, Tortora G, Bria E. Vita E, et al. Among authors: sparagna i. Cancer Immunol Immunother. 2023 Nov;72(11):3803-3812. doi: 10.1007/s00262-023-03533-0. Epub 2023 Sep 5. Cancer Immunol Immunother. 2023. PMID: 37668709 Free PMC article.
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer.
Stefani A, Piro G, Schietroma F, Strusi A, Vita E, Fiorani S, Barone D, Monaca F, Sparagna I, Valente G, Ferrara MG, D'Argento E, Di Salvatore M, Carbone C, Tortora G, Bria E. Stefani A, et al. Among authors: sparagna i. Front Oncol. 2022 Oct 27;12:1026020. doi: 10.3389/fonc.2022.1026020. eCollection 2022. Front Oncol. 2022. PMID: 36387232 Free PMC article. Review.
The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures.
Ferrara MG, Stefani A, Pilotto S, Carbone C, Vita E, Di Salvatore M, D'Argento E, Sparagna I, Monaca F, Valente G, Vitale A, Piro G, Belluomini L, Milella M, Tortora G, Bria E. Ferrara MG, et al. Among authors: sparagna i. Front Oncol. 2021 Dec 23;11:792385. doi: 10.3389/fonc.2021.792385. eCollection 2021. Front Oncol. 2021. PMID: 35004317 Free PMC article. Review.